Arkolith/Insider Trading/APGE/Form 4

Dambkowski Carl

Chief Medical OfficerApogee Therapeutics, Inc. (APGE) · full profile →Form 4 · filed Feb 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$362K
Net Open-Market Flow
-$362K
Transactions
7
6 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 4, 2026Sell(S)100$67.88$7K211K
Feb 4, 2026Sell(S)2K$64.88$161K214K
Feb 4, 2026Option exercise(M)4K$22.86$94K217K
Feb 4, 2026Sell(S)1K$66.85$87K211K
Feb 4, 2026Sell(S)1K$65.83$93K213K
Feb 4, 2026Sell(S)200$68.94$14K211K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 4, 2026Option exercise(M)4K—$0135K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-010454) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML